The preparation, handling and use of intravesical bacillus Calmette-Guerin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 2374197.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The increasing use of bacillus Calmette-Guerin in the treatment of patients with low stage bladder cancer will inevitably bring attention to problems of proper use and toxicity. There is a need to identify patients who are most likely to benefit from this therapy and those who may be at risk for serious complications.
Medical subject headings
- BCG Vaccine
- Carcinoma in Situ
- Carcinoma, Transitional Cell
- Urinary Bladder Neoplasms